India Cements’ Q4 Drama: Sales Slip, Losses Grow-All Eyes on Bold Restructuring Moves

India Cements has reported a tough quarter for the quarter ended March 2025, with standalone net sales declining 3.87% year-on-year to ₹1,197.13 crore from ₹1,245.38 crore in the corresponding quarter last year. The company recorded a heavy standalone net loss of ₹75.66 crore, widening from a loss of ₹29.33 crore in March 2024, and witnessed EBITDA decline steeply by 66.41% to ₹24.03 crore.

Key Highlights:

• Decline in Revenue: Standalone net sales fell 3.87% YoY to ₹1,197.13 crore due to muted demand and price pressure in the cement industry.
• Broadening Losses: Net quarterly loss widened to ₹75.66 crore compared to a loss of ₹29.33 crore last year, indicating continued operating headwinds.
• EBITDA Pressure: EBITDA fell 66.41% to ₹24.03 crore, indicating compression of margins and increasing costs.
• Stock Performance: The shares closed at ₹287.80 on April 24, 2025, posting a six-month return of -18.87%, but a signiflcant 27.01% advance for the twelve months, suggesting the confidence of investors in the prospects of longer-term recovery.
• Restructuring Initiatives: The board sanctioned a draft scheme of amalgamation to consolidate four wholly owned subsidiaries with India Cements, with the objective of simplifying operations and leveraging synergies.
• Ownership Change: After UltraTech Cement acquired the promoters' share, India Cements is currently a subsidiary of the Aditya Birla Group, which may usher in strategic and financial support.
• Annual Perspective: Even though the company faced quarterly setbacks, the company reduced its full-year net loss to ₹143.88 crore from ₹227.34 crore in FY24, which shows improvement at a gradual pace.

India Cements is going through a challenging market environment but is banking on restructuring and new management to drive its turnaround plans.

Sources: Moneycontrol, Business Standard, CNBC-TV18